Li Xin-Yi, Lin Sheng, Lin Yi, Huang Liang-Qing, Xie Xiao-Ming, Tian Gui-Hua
Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.
Zhongguo Zhong Yao Za Zhi. 2023 Jun;48(12):3386-3393. doi: 10.19540/j.cnki.cjcmm.20230311.501.
The present study collected data on traditional Chinese medicine(TCM) compounds effective in relieving pain from the patent database of the State Intellectual Property Office(SIPO), sorted out the TCM compounds against pain in patents, and analyzed the medication rules to provide references for the research and development of new TCM drugs against pain. The data were subjected to frequency statistics, association rules, cluster analysis, and complex network analysis by IBM SPSS Modeler 18.3 and SPSS Statistical 26.0. The results showed that among the 101 oral prescriptions included in the statistics, the top 5 drugs were Glycyrrhizae Radix et Rhizoma, Angelicae Sinensis Radix, Paeoniae Radix Alba, Chuanxiong Rhizoma, and Salviae Miltiorrhizae Radix et Rhizoma, and among the 49 external prescriptions included in the statistics, the top 5 drugs were Myrrha, Olibanum, Angelicae Dahuricae Radix, Borneolum Syntheticum, and Chuanxiong Rhizoma. Whether oral or external prescriptions, the drugs were mainly warm in nature, and bitter, pungent, and sweet in flavor. According to TCM complex network analysis, the core drugs were Glycyrrhizae Radix et Rhizoma, Angelicae Sinensis Radix, Paeoniae Radix Alba, and Chuanxiong Rhizoma in oral prescriptions, and Olibanum, Myrrha, Glycyrrhizae Radix et Rhizoma, Chuanxiong Rhizoma, and Angelicae Sinensis Radix in external prescriptions. Overall, the therapeutic principles of oral prescriptions were mainly replenishing Qi, nourishing blood, and promoting Qi and blood circulation, while those of external prescriptions were activating blood, resolving stasis, promoting Qi flow, and relieving pain on the basis of the oral prescriptions. In the future research and development of TCM compounds against pain, the prescriptions should be modified with mind-tranquilizing and depression-relieving drugs. With the modernization of TCM, the development of new pain-relieving TCM compound patents based on ancient methods and clinical experience adhering to the guidance of TCM treatment based on syndrome differentiation can meet the new demand for pain treatment in the current society and give full play to the advantages of TCM in pain treatment.
本研究从国家知识产权局专利数据库中收集有效止痛的中药复方数据,梳理专利中治疗疼痛的中药复方,分析用药规律,为新型抗痛中药研发提供参考。运用IBM SPSS Modeler 18.3和SPSS Statistical 26.0对数据进行频次统计、关联规则、聚类分析及复杂网络分析。结果显示,纳入统计的101首口服方剂中,使用频次排名前5的药物为甘草、当归、白芍、川芎、丹参;纳入统计的49首外用方剂中,使用频次排名前5的药物为没药、乳香、白芷、冰片、川芎。无论口服还是外用方剂,药物药性以温性为主,药味以苦、辛、甘味为主。根据中医复杂网络分析,口服方剂的核心药物为甘草、当归、白芍、川芎;外用方剂的核心药物为乳香、没药、甘草、川芎、当归。总体而言,口服方剂的治疗原则主要为补气、养血、行气活血;外用方剂在口服方剂基础上,以活血、化瘀、行气止痛为主。在未来抗痛中药复方研发中,应配伍安神解郁类药物进行方剂加减。随着中医现代化,基于古代方法和临床经验,遵循辨证论治指导研发新型抗痛中药复方专利,能够满足当前社会对疼痛治疗的新需求,充分发挥中医在疼痛治疗中的优势。
Zhongguo Zhong Yao Za Zhi. 2023-6
Zhongguo Zhong Yao Za Zhi. 2017-1
Zhongguo Zhong Yao Za Zhi. 2022-2
Zhongguo Zhong Yao Za Zhi. 2022-1
Zhongguo Zhong Yao Za Zhi. 2015-2
Healthcare (Basel). 2023-10-16